HILARY LONG: Open Payments
NPI 1255756219 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,646 in 102 payments from 21 companies in 2025. Trend: 2023 $359 · 2024 $2,464 · 2025 $3,646
Food & beverage: $3,461Education: $185
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 20 | $777 |
| PFIZER INC. | 24 | $668 |
| Janssen Biotech, Inc. | 12 | $575 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $458 |
| Endo USA, Inc. | 4 | $170 |
| Merck Sharp & Dohme LLC | 5 | $135 |
| Tempus AI, Inc | 2 | $134 |
| IMMUNITYBIO, INC. | 1 | $100 |
| Sumitomo Pharma America, Inc. | 3 | $100 |
| SEAGEN INC. | 1 | $85 |
Products named: PROVENGE, XTANDI, ERLEADA, RYBREVANT, Xofigo, Nubeqa, KEYTRUDA, XT CDX.
Industry payments across AZ — which companies pay providers there.
